News from REMEDY

Kristine Røren Nordén has researched how personalized, high-intensity training can improve aerobic capacity in these patients. 

Diseases that form part of the specialty of rheumatology are often referred to as rheumatic diseases or rheumatological diseases. Among the rheumatologists, there are divided opinions about which of these expressions is preferred, and it is the subject of the language column in the journal 25/10/24

The hospital is in the process of completing a state-of-the-art biobank facility at Vinderen. The premises must ensure safe storage of valuable biological material. This is important for the hospital's long-term investment in research and personalized medicine. The facilities will be ready by the end of 2024.

Minister of Health Jan Christian Vestre visited Diakonhjemmet hospital on 15 October. He wants to ensure that the apps in work package 5 do not have to be CE-marked as high-risk medical equipment.

All About Clinical Trials course will be held at Diakonhjemmet hospital, Oslo 12-13. December 2024. It is a generic course that covers all aspects of clinical trials. Although built by cardiologists, it is relevant to anyone interested in clinical trials. The course is particularly suitable for PhD candidates.

New research project on biological medicines:

- This will be a national boost. We hope that we will conduct a study that can change clinical practice, says project manager Silje Watterdal Syversen at the REMEDY centre.

In this webinar, Ingvild Kjeken talks about patient education and lifestyle changes, based on insights that emerged at this year's EULAR conference in Vienna, in June 2024. 

Cand. Med. Ingrid Egeland Christensen has recently completed her doctorate at the Diakonhjemmet Hospital and the research center REMEDY. The dissertation, Serious infections in patients with inflammatory joint diseases, sheds light on the increased risk of serious infections in patients treated with biological drugs.